NEUROTOXIC SIDE-EFFECTS OF CISPLATIN

被引：103

作者：

HAMERS, FPT

GISPEN, WH

NEIJT, JP

机构：

[1] UNIV HOSP UTRECHT, DEPT INTERNAL MED, ONCOL UNIT, HEIDELBERGLAAN 100, 3584 CX UTRECHT, NETHERLANDS

[2] RUDOLF MAGNUS INST PHARMACOL, UTRECHT, NETHERLANDS

来源：

EUROPEAN JOURNAL OF CANCER | 1991年 / 27卷 / 03期

关键词：

D O I：

10.1016/0277-5379(91)90549-S

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：372 / 376

页数：5

共 35 条

[1] EFFECTS OF CORTICOTROPIN (ACTH) ON RECOVERY OF SENSORIMOTOR FUNCTION IN THE RAT - STRUCTURE-ACTIVITY STUDY [J].

BIJLSMA, WA ;

JENNEKENS, FGI ;

SCHOTMAN, P ;

GISPEN, WH .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1981, 76 (01) :73-79

[2] EVALUATION OF CIS-DIAMMINEDICHLOROPLATINUM (II) (CISPLATIN) NEUROTOXICITY IN RATS [J].

DEKONING, P ;

NEIJT, JP ;

JENNEKENS, FGI ;

GISPEN, WH .

TOXICOLOGY AND APPLIED PHARMACOLOGY, 1987, 89 (01) :81-87

[3] EFFICACY AND SAFETY OF HIGH-DOSE CISPLATIN AND CYCLOPHOSPHAMIDE WITH GLUTATHIONE PROTECTION IN THE TREATMENT OF BULKY ADVANCED EPITHELIAL OVARIAN-CANCER [J].

DIRE, F ;

BOHM, S ;

ORIANA, S ;

SPATTI, GB ;

ZUNINO, F .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 25 (05) :355-360

[4] VIBRATION PERCEPTION AND THERMOPERCEPTION AS QUANTITATIVE MEASUREMENTS IN THE MONITORING OF CISPLATIN INDUCED NEUROTOXICITY [J].

ELDERSON, A ;

VANDERHOOP, RG ;

HAANSTRA, W ;

NEIJT, JP ;

GISPEN, WH ;

JENNEKENS, FGI .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 1989, 93 (2-3) :167-174

[5] PHASE-I AND PHASE-II AGENTS IN CANCER-THERAPY - 2 CISPLATIN ANALOGS AND HIGH-DOSE CISPLATIN IN HYPERTONIC SALINE OR WITH THIOSULFATE PROTECTION [J].

FUKS, JZ ;

WADLER, S ;

WIERNIK, PH .

JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 27 (05) :357-365

[6] CLINICAL-TRIALS OF WR-2721 AND CIS-PLATINUM [J].

GLOVER, D ;

GRABELSKY, S ;

FOX, K ;

WEILER, C ;

CANNON, L ;

GLICK, J .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 16 (05) :1201-1204

[7] PHASE I/II TRIALS OF WR-2721 AND CISPLATINUM [J].

GLOVER, D ;

GLICK, JH ;

WEILER, C ;

FOX, K ;

TURRISI, A ;

KLIGERMAN, MM .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1986, 12 (08) :1509-1512

[8] PROGRESSIVE PARESTHESIAS AFTER CESSATION OF THERAPY WITH VERY HIGH-DOSE CISPLATIN [J].

GRUNBERG, SM ;

SONKA, S ;

STEVENSON, LL ;

MUGGIA, FM .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 25 (01) :62-64

[9] HIGH-DOSE CISPLATIN COMBINATION CHEMOTHERAPY IN THE TREATMENT OF ADVANCED EPITHELIAL OVARIAN-CARCINOMA [J].

HAINSWORTH, JD ;

BURNETT, LS ;

JONES, HW ;

GROSH, WW ;

JOHNSON, DH ;

GRECO, FA .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (03) :502-508

[10] THE CALCIUM-ANTAGONIST NIMODIPINE IN CISPLATIN-INDUCED NEUROPATHY IN THE RAT [J].

HAMERS, FPT ;

VANDERHOOP, RG ;

TRABER, J ;

NEIJT, JP ;

JENNEKENS, FGI ;

GISPEN, WH .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (05) :1710-1710

← 1 2 3 4 →